People

Palamar-276-303
Joseph Palamar, PhD, MPH
NYU Langone Health - Associate Professor, Department of Population Health
Email: joseph.palamar@nyu.edu
Education
PhD, Public Health, New York University
MPH, Public Health, New York University
MA, Educational Psychology, New York University
BA, Forensic Psychology, John Jay College of Criminal Justice
Research Interests
Epidemiology of illicit drug use, club drugs, new psychoactive substances, stigma, risky sexual intercourse
BIO
Joseph Palamar’s research and publication record reflect his commitment to investigate the epidemiology of drug use. He has a diverse background in psychology, epidemiology, and in the study of drug use, and specializes in psychosocial correlates of drug use. He has focused heavily on the epidemiology of new psychoactive substance use, “club drug” use, and drug-related risky sexual behavior — especially within the electronic dance music (EDM) nightclub and festival scene. He also has extensive experience analyzing data from large national datasets such as Monitoring the Future and the National Survey on Drug Use and Health.
Projects
Principal Investigator, Investigating the Ketamine Landscape: Availability, Medical and Recreational Use, and Effects. Active
Principal Investigator, New Psychoactive Substance Exposure among NYC Nightclub and Festival Attendees. Active
Principal Investigator, Development of a Rapid Survey to Detect Use of New and Emerging Drugs. Completed
Principal Investigator, Drug Use Among Nightclub and Dance Festival Attendees in New York City. Completed
Principal Investigator, Pilot Study Examining the Sexual Effects of Cannabis Use. Completed
Principal Investigator, Pilot Study to Collect Saliva and Follow-up Survey Response Rates among EDM Party Attendees. Completed
Principal Investigator, Use of Psychoactive Drugs and Sexual Risk Behavior among Nightclub and Festival Attendees. Completed
Publications

Recent

Palamar JJ, Fitzgerald ND, Goldberger BA, Cottler LB (2024).
Monitoring illicit pentobarbital availability in the United States: A National Drug Early Warning System briefing
Drug and Alcohol Dependence, 263, 112402. doi: 10.1016/j.drugalcdep.2024.112402. PMCID: PMC11384643.

Palamar JJ, Krotulski AJ (2024).
Medetomidine infiltrates the US illicit opioid market
JAMA [Epub 2024 Sep 4]. doi: 10.1001/jama.2024.15992.

Han BH, Pettus JH, Yang KH, Moore AA, Palamar JJ (2024).
Past-month cannabis use among adults with diabetes in the U.S., 2021-2022
Diabetes Care, 47 (9), e67-e69. doi: 10.2337/dc24-0597. PMCID: PMC11362118.

Bruzelius E, Palamar JJ, Fitzgerald ND, Cottler LB, Carr TC, Martins SS (2024).
Law enforcement fentanyl seizures and overdose mortality in US counties, 2013-2020
Drug and Alcohol Dependence, 262, 111400. doi: 10.1016/j.drugalcdep.2024.111400.

Han BH, Palamar JJ, Moore AA, Schwartz RP, Wu LT, Subramaniam G, McNeely J (2024).
Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) tool in screening older adults for unhealthy substance use
Journal of Addiction Medicine [Epub 2024 Aug 12]. doi: 10.1097/adm.0000000000001363.

Dr. Palamar's MyBibliography Profile
Selected Press